Mizuho Securities Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $55

Moomoo NewsDec 23 08:32 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and IDEAYA Biosciences (IDYA)

TipRanksDec 23 08:01 ET · Ratings

Companies Like IDEAYA Biosciences (NASDAQ:IDYA) Are In A Position To Invest In Growth

Simply Wall StDec 20 06:20 ET

IDEAYA Biosciences (IDYA) Receives a Hold From Leerink Partners

TipRanksDec 18 00:37 ET · Ratings

RBC Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $61

Moomoo NewsDec 17 12:31 ET · Ratings

Express News | Cantor Fitzgerald Reiterates Overweight on IDEAYA Biosciencesto Overweight

BenzingaDec 17 09:03 ET